Argenx Se (ARGX) Revenue Growth (1y) (2017 - 2026)

Argenx Se (ARGX) Revenue Growth (1y) (2017 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue Growth (1y) (Qtr)
1 Oculis Holding AG 68,725.60 Bn 68,725.31 Bn - -
2 Nanobiotix 1,953.19 Bn 1,953.13 Bn - -
3 Akari Therapeutics 1,132.35 Bn 1,132.35 Bn - -
4 BeOne Medicines 472.73 Bn 467.94 Bn 1.35 Bn 35.46%
5 Vertex Pharmaceuticals 123.52 Bn 116.27 Bn 2.59 Bn 7.82%
6 Regeneron Pharmaceuticals 69.74 Bn 60.99 Bn 3.31 Bn 19.04%
7 Belite Bio 63.09 Bn 63.09 Bn - -
8 Argenx Se 56.42 Bn 51.24 Bn 1.41 Bn 64.03%
9 Revolution Medicines 37.76 Bn 37.76 Bn - -
10 Alnylam Pharmaceuticals 37.40 Bn 34.39 Bn 959.66 Mn 96.43%

Historic Data

Download Data
DateValue
Jun 30, 2026 64.03%
Mar 31, 2026 64.30%
Dec 31, 2025 74.46%
Sep 30, 2025 96.68%
Jun 30, 2025 98.60%
Mar 31, 2025 98.35%
Dec 31, 2024 96.87%
Sep 30, 2024 74.11%
Jun 30, 2024 77.35%
Mar 31, 2024 82.68%
Dec 31, 2023 115.89%
Sep 30, 2023 150.59%
Jun 30, 2023 259.89%
Mar 31, 2023 930.20%
Dec 31, 2022 566.34%
Sep 30, 2022 -99.98%
Jun 30, 2022 -76.25%
Mar 31, 2022 -86.07%
Dec 31, 2021 -6.56%
Sep 30, 2021 9,813,632.52%